Loading...
•
Mar 31, 2022
TherapeuticsMD Q1 2022 Earnings Report
Reported financial results for the first quarter ended March 31, 2022.
Key Takeaways
TherapeuticsMD reported a total net product revenue of $19.3 million for Q1 2022. ANNOVERA TRx reached 8,014, a 27% increase over Q1 2021. The company completed the vitaCare divestiture in five weeks.
Total net product revenue was $19.3 million.
ANNOVERA TRx reached 8,014, a 27% increase over Q1 2021.
Completed vitaCare divestiture in five weeks.
Net loss for the first quarter of 2022 was $49.0 million, or $5.69 per basic and diluted share.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...